|
1
|
Dome JS, Rodriguez-Galindo C, Spunt SL and
Santana V: Pediatric solid tumors. Clinical Oncology. Abeloff MD,
Armitage JO, Niederhuber JE, Kastan MB and McKenna WG: 4th edition.
Churchill Livingstone, Elsevier; Philadelphia, PA: pp. 2661–2722.
2008
|
|
2
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fish JD and Grupp SA: Stem cell
transplantation for neuroblastoma. Bone Marrow Transplant.
41:159–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haase GM, Perez C and Atkinson JB: Current
aspects of biology, risk assessment, and treatment of
neuroblastoma. Semin Surg Oncol. 16:91–104. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson E, Dean SM and Sondel PM:
Antibody-based immunotherapy in high-risk neuroblastoma. Expert Rev
Mol Med. 9:1–21. 2007. View Article : Google Scholar
|
|
6
|
Coderch C, Morreale A and Gago F:
Tubulin-based structure-affinity relationships for antimitotic
Vinca alkaloids. Anticancer Agents Med Chem. 12:219–225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qaddoumi I, Billups CA, Tagen M, et al:
Topotecan and vincristine combination is effective against advanced
bilateral intraocular retinoblastoma and has manageable toxicity.
Cancer. Apr 19–2012.(Epub ahead of print).
|
|
8
|
Packer RJ, Ater J, Allen J, et al:
Carboplatin and vincristine chemotherapy for children with newly
diagnosed progressive low-grade gliomas. J Neurosurg. 86:747–754.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knudson AG: Two genetic hits (more or
less) to cancer. Nat Rev Cancer. 1:157–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Conway RM, Madigan MC, Billson FA and
Penfold PL: Vincristine- and cisplatin-induced apoptosis in human
retinoblastoma. Potentiation by sodium butyrate. Eur J Cancer.
34:1741–1748. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Groninger E, Meeuwsen-De Boer GJ, De Graaf
SS, Kamps WA and De Bont ES: Vincristine-induced apoptosis in acute
lymphoblastic leukaemia cells: A mitochondrial controlled pathway
regulated by reactive oxygen species? Int J Oncol. 21:1339–1345.
2002.
|
|
12
|
Lee HZ, Leung HW, Lai MY and Wu CH:
Baicalein induced cell cycle arrest and apoptosis in human lung
squamous carcinoma CH27 cells. Anticancer Res. 25:959–964.
2005.PubMed/NCBI
|
|
13
|
Blajeski AL, Phan VA, Kottke TJ and
Kaufmann SH: G(1) and G(2) cell-cycle arrest following microtubule
depolymerization in human breast cancer cells. J Clin Invest.
110:91–99. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baker DL, Schmidt ML, Cohn SL, et al:
Outcome after reduced chemotherapy for intermediate-risk
neuroblastoma. N Engl J Med. 363:1313–1323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haim N, Epelbaum R, Ben-Shahar M,
Yarnitsky D, Simri W and Robinson E: Full dose vincristine (without
2-mg dose limit) in the treatment of lymphomas. Cancer.
73:2515–2519. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie HR, Hu LS and Li GY: SH-SY5Y human
neuroblastoma cell line: in vitro cell model of dopaminergic
neurons in Parkinson's disease. Chin Med J (Engl). 123:1086–1092.
2010.
|
|
17
|
Gupta A, Inaba S, Wong OK, Fang G and Liu
J: Breast cancer-specific gene 1 interacts with the mitotic
checkpoint kinase BubR1. Oncogene. 22:7593–7599. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Madhavan J, Ganesh A and Kumaramanickavel
G: Retinoblastoma: from disease to discovery. Ophthalmic Res.
40:221–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singh VK, Zhou Y, Marsh JA, et al:
Synuclein-gamma targeting peptide inhibitor that enhances
sensitivity of breast cancer cells to antimicrotubule drugs. Cancer
Res. 67:626–633. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jordan MA: Mechanism of action of
antitumor drugs that interact with microtubules and tubulin. Curr
Med Chem Anticancer Agents. 2:1–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matthay KK, Villablanca JG, Seeger RC, et
al: Treatment of high-risk neuroblastoma with intensive
chemotherapy, radiotherapy, autologous bone marrow transplantation,
and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med.
341:1165–1173. 1999. View Article : Google Scholar
|
|
22
|
Zoubek A, Holzinger B, Mann G, et al:
High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in
children with recurrent solid tumor. Pediatr Hematol Oncol.
11:613–623. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rubie H, Coze C, Plantaz D, et al:
Localised and unresectable neuroblastoma in infants: excellent
outcome with low-dose primary chemotherapy. Br J Cancer.
89:1605–1609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kotchetkov R, Cinatl J, Blaheta R, et al:
Development of resistance to vincristine and doxorubicin in
neuroblastoma alters malignant properties and induces additional
karyotype changes: a preclinical model. Int J Cancer. 104:36–43.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ford HL and Pardee AB: Cancer and the cell
cycle. J Cell Biochem Suppl. 32–33:166–172. 1999.
|
|
26
|
Cuddihy AR and O'Connell MJ: Cell-cycle
responses to DNA damage in G2. Int Rev Cytol. 222:99–140. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kung AL, Zetterberg A, Sherwood SW and
Schimke RT: Cytotoxic effects of cell cycle phase specific agents:
result of cell cycle perturbation. Cancer Res. 50:7307–7317.
1990.PubMed/NCBI
|
|
28
|
Shi JH, Xu XP, Zhang ZL, Zhang JS, Ge JB
and Cheng WY: Inhibition of activation of nuclear factor-kappaB
enhanced apoptosis of leukemic cells induced by homoharringtonine.
Zhonghua Nei Ke Za Zhi. 42:292–295. 2003.(In Chinese).
|
|
29
|
Shinwari Z, Al-Hindi H, Al-Shail E, et al:
Response of medulloblastoma cells to vincristine and lomustine:
role of TRKC, CTNNB1 and STK15. Anticancer Res. 31:1721–1733.
2011.PubMed/NCBI
|
|
30
|
Sung KH, Lee EH and Kim YZ: Factors
influencing the response to high dose methotrexate-based
vincristine and procarbazine combination chemotherapy for primary
central nervous system lymphoma. J Korean Med Sci. 26:551–560.
2011. View Article : Google Scholar
|
|
31
|
Zhang J, Chatterjee K, Alano CC,
Kalinowski MA, Honbo N and Karliner JS: Vincristine attenuates
N-methyl-N′-nitro-N-nitrosoguanidine-induced poly-(ADP) ribose
polymerase activity in cardiomyocytes. J Cardiovasc Pharmacol.
55:219–226. 2010.PubMed/NCBI
|
|
32
|
Salvesen GS: Caspases: opening the boxes
and interpreting the arrows. Cell Death Differ. 9:3–5. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simpson MT, MacLaurin JG, Xu D, et al:
Caspase 3 deficiency rescues peripheral nervous system defect in
retinoblastoma nullizygous mice. J Neurosci. 21:7089–7098.
2001.PubMed/NCBI
|
|
34
|
Hajnoczky G, Davies E and Madesh M:
Calcium signaling and apoptosis. Biochem Biophys Res Commun.
304:445–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
